(Q48314637)

10 February 2018

title

Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours (English)

1 reference

10 February 2018

0 references

1 reference

de Keyzer Y

1

1 reference

10 February 2018

René P

2

1 reference

10 February 2018

Beldjord C

3

1 reference

10 February 2018

Lenne F

4

1 reference

10 February 2018

Bertagna X

5

1 reference

10 February 2018

publication date

1 October 1998

1 reference

10 February 2018

published in

Clinical Endocrinology

1 reference

10 February 2018

volume

49

1 reference

10 February 2018

issue

4

1 reference

10 February 2018

page(s)

475-482

1 reference

10 February 2018

Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

Cloning and characterization of the human V3 pituitary vasopressin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

Inferior petrosal sinus arginine vasopressin concentrations in normal volunteers and patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

Phosphoinositide-specific phospholipase C and mitogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosph

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

Vasopressin rapidly stimulates phosphatidic acid-phosphatidylinositol turnover in rat anterior pituitary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

The Human V3Pituitary Vasopressin Receptor: Ligand Binding Profile and Density-Dependent Signaling Pathways1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

Arginine vasopressin in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00560.X

10.1046/J.1365-2265.1998.00560.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018